UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Circulating Tumor DNA Assays in Clinical Cancer Research

JNCI : Journal of the National Cancer Institute, 2018-09, Vol.110 (9), p.929-934

2018

Link zum Volltext

Verfügbarkeit prüfen

Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials

Clinical cancer research, 2016-07, Vol.22 (13), p.3138-3147

2016

Link zum Volltext

Verfügbarkeit prüfen

Dual Inhibition of the PI3K/mTOR Pathway Increases Tumor Radiosensitivity by Normalizing Tumor Vasculature

Cancer research (Chicago, Ill.), 2012, Vol.72 (1), p.239-248

2012

Link zum Volltext

Verfügbarkeit prüfen

Tumor Vascular Changes Mediated by Inhibition of Oncogenic Signaling

Cancer research (Chicago, Ill.), 2009-08, Vol.69 (15), p.6347-6354

2009

Link zum Volltext

Verfügbarkeit prüfen

NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity

Radiation oncology (London, England), 2012-03, Vol.7 (1), p.48-48, Article 48

2012

Link zum Volltext

Verfügbarkeit prüfen

Class I PI3 kinase inhibition by the pyridinylfuranopyrimidine inhibitor PI-103 enhances tumor radiosensitivity

Cancer research (Chicago, Ill.), 2008-07, Vol.68 (14), p.5915-5923

2008

Link zum Volltext

Verfügbarkeit prüfen

A Small Interfering RNA Screen of Genes Involved in DNA Repair Identifies Tumor-Specific Radiosensitization by POLQ Knockdown

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (7), p.2984-2993

2010

Link zum Volltext

Verfügbarkeit prüfen

Preclinical Data on Efficacy of 10 Drug-Radiation Combinations: Evaluations, Concerns, and Recommendations

Translational oncology, 2016-02, Vol.9 (1), p.46-56

2016

Link zum Volltext

Verfügbarkeit prüfen

Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines

Cancer research (Chicago, Ill.), 2005-09, Vol.65 (17), p.7902-7910

2005

Link zum Volltext

Verfügbarkeit prüfen

Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth

Cancer cell, 2004-12, Vol.6 (6), p.597-609

2004

Link zum Volltext

Verfügbarkeit prüfen

Mutant epidermal growth factor receptor displays increased signaling through the phosphatidylinositol-3 kinase AKT pathway and promotes radioresistance in cells of astrocytic origin

Oncogene, 2004-06, Vol.23 (26), p.4594-4602

2004

Link zum Volltext

Verfügbarkeit prüfen

Radiation—Therapeutic Agent Clinical Trials: Leveraging Advantages of a National Cancer Institute Programmatic Collaboration

Seminars in radiation oncology, 2016-10, Vol.26 (4), p.271-280

2016

Link zum Volltext

Verfügbarkeit prüfen

The RAS signal transduction pathway and its role in radiation sensitivity

Oncogene, 2003-09, Vol.22 (37), p.5866-5875

2003

Link zum Volltext

Verfügbarkeit prüfen

Oncogenic K-Ras Signals through Epidermal Growth Factor Receptor and Wild-Type H-Ras to Promote Radiation Survival in Pancreatic and Colorectal Carcinoma Cells

Neoplasia (New York, N.Y.), 2007-04, Vol.9 (4), p.341-348

2007

Link zum Volltext

Verfügbarkeit prüfen

Overview and Lessons From the Preclinical Chemoradiotherapy Testing Consortium

International journal of radiation oncology, biology, physics, 2021-12, Vol.111 (5), p.1126

2021

Link zum Volltext

Verfügbarkeit prüfen

The Future of Radiobiology

JNCI : Journal of the National Cancer Institute, 2018-04, Vol.110 (4), p.329-340

2018

Link zum Volltext

Verfügbarkeit prüfen

RhoB Is Required to Mediate Apoptosis in Neoplastically Transformed Cells after DNA Damage

Proceedings of the National Academy of Sciences - PNAS, 2001-05, Vol.98 (11), p.6192-6197

2001

Link zum Volltext

Verfügbarkeit prüfen

Human cancer long non-coding RNA transcriptomes

PloS one, 2011-10, Vol.6 (10), p.e25915-e25915

2011

Link zum Volltext

Verfügbarkeit prüfen

MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells

PloS one, 2009-08, Vol.4 (8), p.e6816

2009

Link zum Volltext

Verfügbarkeit prüfen

Radioprotectors and Radiomitigators for Improving Radiation Therapy: The Small Business Innovation Research (SBIR) Gateway for Accelerating Clinical Translation

Radiation research, 2015-09, Vol.184 (3), p.235

2015

Link zum Volltext

Verfügbarkeit prüfen

A Phase I Trial of the Dual Farnesyltransferase and Geranylgeranyltransferase Inhibitor L-778,123 and Radiotherapy for Locally Advanced Pancreatic Cancer

Clinical cancer research, 2004-08, Vol.10 (16), p.5447-5454

2004

Link zum Volltext

Verfügbarkeit prüfen

Modulating Tumor Vasculature through Signaling Inhibition to Improve Cytotoxic Therapy

Cancer research (Chicago, Ill.), 2010-03, Vol.70 (6), p.2141-2145

2010

Link zum Volltext

Verfügbarkeit prüfen

A Phase I Trial of the Farnesyltransferase Inhibitor L-778,123 and Radiotherapy for Locally Advanced Lung and Head and Neck Cancer

Clinical cancer research, 2002-05, Vol.8 (5), p.1065-1072

2002

Link zum Volltext

Verfügbarkeit prüfen

A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses

PloS one, 2010-05, Vol.5 (5), p.e10431

2010

Link zum Volltext

Verfügbarkeit prüfen

Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis

PloS one, 2011-04, Vol.6 (4), p.e18801-e18801

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 583

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(553)
Mit Volltextzugriff
(517)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(443)
Life Sciences & Biomedicine
(299)
Humans
(286)
Animals
(133)
Female
(116)
Male
(104)
Science & Technology - Other Topics
(102)
Biological And Medical Sciences
(98)
Multidisciplinary Sciences
(98)
Oncology
(94)
Medical Sciences
(75)
Tumors
(75)
Mice
(74)
Cancer
(71)
Middle Aged
(65)
Biology
(58)
Adult
(53)
Physical Sciences
(53)
Medicine
(50)
Genomes
(49)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(72)
Cancer Research
(23)
Nature Genetics
(16)
Cancer Biology & Therapy
(12)
Nature
(11)
Proceedings Of The National Academy Of Sciences - Pnas
(9)
Radiation Research
(9)
Clinical Cancer Research
(7)
Plos Genetics
(7)
Science
(7)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Circulating Tumor DNA Assays in Clinical Cancer Research

Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials

Dual Inhibition of the PI3K/mTOR Pathway Increases Tumor Radiosensitivity by Normalizing Tumor Vasculature

Tumor Vascular Changes Mediated by Inhibition of Oncogenic Signaling

NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity

Class I PI3 kinase inhibition by the pyridinylfuranopyrimidine inhibitor PI-103 enhances tumor radiosensitivity

A Small Interfering RNA Screen of Genes Involved in DNA Repair Identifies Tumor-Specific Radiosensitization by POLQ Knockdown

Preclinical Data on Efficacy of 10 Drug-Radiation Combinations: Evaluations, Concerns, and Recommendations

Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines

Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth

Mutant epidermal growth factor receptor displays increased signaling through the phosphatidylinositol-3 kinase AKT pathway and promotes radioresistance in cells of astrocytic origin

Radiation—Therapeutic Agent Clinical Trials: Leveraging Advantages of a National Cancer Institute Programmatic Collaboration

The RAS signal transduction pathway and its role in radiation sensitivity

Oncogenic K-Ras Signals through Epidermal Growth Factor Receptor and Wild-Type H-Ras to Promote Radiation Survival in Pancreatic and Colorectal Carcinoma Cells

Overview and Lessons From the Preclinical Chemoradiotherapy Testing Consortium

The Future of Radiobiology

RhoB Is Required to Mediate Apoptosis in Neoplastically Transformed Cells after DNA Damage

Human cancer long non-coding RNA transcriptomes

MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells

Radioprotectors and Radiomitigators for Improving Radiation Therapy: The Small Business Innovation Research (SBIR) Gateway for Accelerating Clinical Translation

A Phase I Trial of the Dual Farnesyltransferase and Geranylgeranyltransferase Inhibitor L-778,123 and Radiotherapy for Locally Advanced Pancreatic Cancer

Modulating Tumor Vasculature through Signaling Inhibition to Improve Cytotoxic Therapy

A Phase I Trial of the Farnesyltransferase Inhibitor L-778,123 and Radiotherapy for Locally Advanced Lung and Head and Neck Cancer

A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses

Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis

Suchergebnisse filtern